Abstract
Efficacy of postsynaptic inhibition through GABAAreceptors in the mammalian brain depends on the maintenance of a Cl− gradient for hyperpolarizing Cl− currents. We have taken advantage of the reduced complexity under which Cl− regulation can be investigated in cultured neurons as opposed to neurons in otherin vitro preparations of the mammalian brain. Tightseal whole-cell recording of spontaneous GABAAreceptor-mediated postsynaptic currents suggested that an outward Cl− transport reduced dendritic [Cl−]i if the somata of cells were loaded with Cl− via the patch pipette. We determined dendritic and somatic reversal potentials of Cl− currents induced by focally applied GABA to calculate [Cl−]i during variation of [K+]o and [Cl−] in the patch pipette. [Cl−]i and [K+]o were tightly coupled by a furosemide-sensitive K+–Cl−cotransport. Thermodynamic considerations excluded the significant contribution of a Na+–K+–Cl−cotransporter to the net Cl− transport. We conclude that under conditions of normal [K+]othe K+–Cl− cotransporter helps to maintain [Cl−]i at low levels, whereas under pathological conditions, under which [K+]o remains elevated because of neuronal hyperactivity, the cotransporter accumulates Cl− in neurons, thereby further enhancing neuronal excitability.
- Cl− homeostasis
- K+–Cl− cotransporter
- furosemide
- Cl− depletion
- Cl−accumulation
- Donnan equilibrium
- cultured neurons
GABA is the main inhibitory transmitter in the mammalian brain. The dominant effect of GABAA receptor activation is a hyperpolarization caused by Cl− flux into the cell (for review, see Sivilotti and Nistri, 1991; Kaila, 1994; Thompson, 1994). However, the direction of the Cl− flux depends on the Cl− gradient across the membrane. Indeed, GABAA receptor-mediated hyperpolarizing and/or depolarizing postsynaptic potentials have been observed (for review, see Kaila, 1994; Thompson, 1994). Some findings suggest variations in intracellular [Cl−] between different neurons and even a distinct Cl− distribution in different compartments of a single neuron (Misgeld et al., 1986). Depolarizing GABAA responses, however, can be caused by bicarbonate efflux in combination with Cl− influx or combined Cl− and HCO3−efflux (Grover et al., 1993; Kaila, 1994; Thompson, 1994; Staley et al., 1995; Perkins and Wong, 1996; Kaila et al., 1997). To be able to predict the direction of Cl− currents flowing during GABAA receptor-mediated inhibition it is essential to understand the regulation of Cl− homeostasis that provides the transmembrane gradient.
A recently cloned K+–Cl−cotransporter gene (KCC2) represents a perfect candidate for the regulation of neuronal Cl− homeostasis (Payne et al., 1996). In contrast to the ubiquitous presence of the K+–Cl− cotransporter KCC1, expression of the K+–Cl−cotransporter KCC2 is detected in CNS only and seems to be neuron specific. KCC2 is also distinct from KCC1 in that KCC2 is not involved in cell volume regulation and not activated by osmotic changes. Furthermore, KCC2 has a high affinity for extracellular K+ ions. The properties of KCC2 allow the regulation of [Cl−]i to maintain Cl− gradients for hyperpolarizing GABAergic inhibition. Thermodynamic considerations predict that the electroneutral K+–Cl−cotransporter KCC2 operates near equilibrium under physiological ionic conditions. Depending on [Cl−]i and [K+]o (Payne, 1997), the transport will extrude or accumulate Cl−.
The functional role of a particular Cl− transport system in neuronal Cl− regulation is difficult to establish in studies using integral preparations such as brain slices. One complicating factor is the presence of HCO3− anions. The HCO3− permeability of the GABAA channel (Bormann, 1988; Fatima-Shad and Barry, 1993) impedes conclusions toward actual [Cl−]i if they are calculated from reversal potentials of GABAA receptor-mediated anion currents. Furthermore, a HCO3−/Cl− exchanger (Raley-Susman et al., 1993) may well interfere (Chesler, 1990), and pH changes that result from manipulations of [HCO3−]o strongly affect neuronal excitability (Jarolimek et al., 1989; Chesler and Kaila, 1992).
To investigate the functional role of Cl−transporters we used neuronal cultures that allow measurements of Cl− reversal potentials under nominally HCO3−-free conditions. We used patch pipettes to manipulate [Cl−]i and tested [Cl−]i regulation in somatic and dendritic compartments by varying [K+]o. The K+–Cl− cotransporter KCC2 is furosemide sensitive (Payne, 1997), so we used furosemide to test the inward or outward direction of the Cl− transport in cultured neurons. We found that a transport with properties of the neuronal-specific K+–Cl−cotransporter KCC2 can fully account for Cl−regulation in cultured midbrain neurons.
MATERIALS AND METHODS
Cell culture. Pregnant Wistar rats were anesthetized by ether inhalation and killed by decapitation. The embryos were removed, placed in sterile, ice-cold Gey’s buffered salt solution containing (in mm): NaCl 137,KCl 5, MgSO4 0.3, NaH2PO4 1, CaCl2 1.5, NaHCO3 2.7, KH2PO4 0.2, MgCl2 1, glucose 5, at pH 7.4, and immediately decapitated. Pieces of ventral midbrain tissue from the 14-d-old embryos were mechanically dissociated and plated on a primary culture of glial cells from the same area. Cell culture conditions were as described previously (Bijak et al., 1991; Jarolimek and Misgeld, 1992). Cells used in this study were 4–8 weeks in culture. Immunocytochemistry studies have shown that this culture preparation contains ∼5% dopaminergic neurons and <5% serotonergic neurons (Rohrbacher et al., 1995) in addition to ∼70% GABAergic neurons (our unpublished results). The fact that EPSPs attributable to activation of glutamatergic receptors comprise a significant proportion of the observed postsynaptic activity (Bijak et al., 1991) suggests that most non-GABAergic neurons possess a glutamatergic neurotransmitter phenotype.
Electrophysiological recordings. Recordings were performed at room temperature (22–25°C) in the whole-cell voltage-clamp configuration with a patch-clamp amplifier (L/M-EPC 7, List, Darmstadt, Germany). The composition of the extracellular solutions and the patch pipette solutions are given in Table 1. No CO2 or O2 was added, and the pH of all solutions was adjusted to 7.3. Glucuronate salts were used because the permeability of the anion through GABAA channels should be small because of its restricted, bulky conformation. 5-N-(2,6-dimethyl-phenylcarbamoylmethyl)-triethylammonium bromide (QX314) was added to the intracellular solution to block Na+ and K+ currents (Connors and Prince, 1982; Nathan et al., 1990; Colling and Wheal, 1994). The Br− salt was used because in initial experiments the block of action potentials was faster and more complete with Br− than with the Cl− salt. Br− has a permeability similar to that of Cl− at GABAA channels (Bormann, 1988); therefore, concentrations of permeable ions used for calculations were the sum of Cl− and Br−concentrations. The reliability of this approach was tested by replacement of 5 mm[Cl−]o by 5 mm[Br−]o to obtain an identical [Br−] in the extracellular solution and the patch pipette. This change had no measurable influence on reversal potentials of GABA-induced currents (n = 4). We did not replace K+ by Cs+ in the patch pipette because Cs+ could interfere with the presumed K+–Cl− cotransporter competing with K+ for the internal binding site and/or changing the driving force for the transporter. CsCl was added, however, to the extracellular solution to reduce leak conductance. In preliminary experiments we tested whether extracellular Cs+ affected the K+–Cl− cotransporter. Furosemide (0.1 mm) shifted the dendritic reversal potential (EGABA) of GABA-induced currents (IGABA) in a positive direction at 2 mm [K+]o and in a negative direction at 10 mm[K+]o and low [Cl−]pip (see Results). Neither dendritic EGABA nor its shifts that were induced by furosemide changed when we added 5 mmCs+ (n = 5), suggesting that Cs+ was not a substrate for the transporter and did not compete for the extracellular binding site of K+. Therefore the extracellular solution always contained 5 mm Cs+ to reduce leak conductance when we measured reversal potentials for GABA currents. Spontaneous synaptic activity in the embryonic midbrain culture consists of EPSCs that are blocked by the AMPA-type glutamate antagonist 6,7-dinitroquinoxaline-2,3-dione (DNQX) and IPSCs sensitive to antagonists for the GABAA receptors bicuculline or picrotoxin (Bijak et al., 1991; Jarolimek and Misgeld, 1991). To block excitation, DNQX (20 μm) and the NMDA receptor-type antagonist dl-2-amino-4-methyl-5-phosphono-3-pentenoic acid (1 μm) were present in all extracellular recording solutions.
Patch pipettes were fabricated from borosilicate glass (Hilgenberg, Malsfeld, Germany), and their resistances to bath ranged from 2 to 4 MΩ. The access resistance was estimated from the amplitude of the capacitive current evoked by a hyperpolarizing 10 mV step. Access resistances varied between 5 and 12 MΩ and were routinely checked during the recording. No series resistance or slow capacitance compensation was used during the experiment because currents were measured >15 sec after the membrane potential was changed. Given the small amplitude (<200 pA) of the recorded currents, series resistance error was <2.5 mV. The liquid junction potential between the patch pipette and the extracellular solution was calculated according toBarry and Lynch (1991). The calculation yielded 15.8 and 17.5 mV for 15 and 4.5 mm[A−]pip, respectively. When measured according to the procedure described by Neher (1992), the values were 14.0 and 15.5 mV, respectively, which are in good agreement with the calculated values. Because it has been suggested that calculated rather than measured values be used (Barry and Lynch, 1991), all potentials reported in this paper have been corrected for the calculated liquid junction potentials.
Recordings were started >5 min after the whole-cell configuration was established to allow adequate time for QX314 to take effect and for anions to equilibrate. After 5 min, no further change in dendritic or somatic EGABA was observed. GABA (1 mm) was applied by pressure ejection (1–20 kPa, 20–40 msec) every 15 sec from a pipette with a <1 μm opening.IGABA was measured in the presence of tetrodotoxin (0.3 μm) to avoid superposition ofIGABA and action potential-dependent IPSCs as well as the activation of fast Na+ currents in the recorded cell. All inorganic salts were of analytical grade (Merck, Darmstadt, Germany). Drugs were from Sigma (Deisenhofen, Germany) except DNQX and tetrodotoxin (RBI, Köln, Germany).
Extracellular solutions were applied by a multibarrel perfusion system that was positioned ∼250 μm away from the soma of the recorded cell (Bijak et al., 1991; Jarolimek and Misgeld, 1992).
Data analysis. Recordings were filtered at 1.3–3 kHz with a four-pole Bessel filter, acquired and analyzed with pClamp (Axon Instruments, Foster City, CA) hardware and software, and additionally stored on a DAT recorder. The time course and amplitude of spontaneous IPSCs (sIPSCs) were analyzed with a program written in our laboratory (Jarolimek and Misgeld, 1997; Rohrbacher et al., 1997). The reversal potential of IGABA was determined by linear regression of the current–voltage relationship. Currents were recorded at holding potentials (VH) on both sides of EGABA. After 15–45 sec at a newVH, the current amplitudes induced by three consecutive applications were averaged. Despite the rapid exchange of the extracellular solution (∼0.5 sec) around the neuron, effects were determined >1 min after the start of the application to achieve steady-state conditions. Theoretical [Cl−]i of the neuron was calculated with the Nernst equation using measured EGABAvalues and [Cl−]o values given in Table 1. Calculated values were not corrected for the presence of Br− in the pipette and in the neuron. The driving force for the K+–Cl−cotransporter was estimated on the basis of the Nernst equation given the calculated [Cl−]i and [K+]o from Table 1. Data are reported as mean ± SEM.
RESULTS
Cl− gradient between soma and dendrites
When tight-seal whole-cell recordings were performed under conditions of 15 mm permeant anions in the patch pipette ([A−]pip), 2 mm[K+]o, and pharmacological blockade of ionotropic glutamate receptors, sIPSCs did not reverse in sign at a defined holding potential (VH). Instead, at VH in a range near the reversal potential (ECl = −61 mV as determined from the Nernst equation), inward and outward sIPSCs concurred in 46 of 51 cells (Fig. 1A). All sIPSCs were blocked by bicuculline (n = 5), suggesting that they were mediated by GABAA receptors (Fig.1B). Inward and outward sIPSCs appeared to be separated (Fig. 1A1) or as sequences of inward currents curtailed by outward currents (Fig. 1A2). As shown in Figure 1A3, another pattern consisted of clustered inward sIPSCs that were accompanied by a continuous barrage of outward sIPSCs or vice versa. We analyzed the time courses of apparently isolated inward and outward sIPSCs in a single cell at aVH at which amplitudes of inward and outward IPSCs were in a similar range (Fig. 1C,D). There was a clear difference in the time courses. Outward sIPSCs consistently had a slower rise time and time constant of decay than inward sIPSCs (rise time, 1.9 ± 0.1 msec vs 5.3 ± 0.4 msec; decay time constant, 16.2 ± 1.3 msec vs 38.6 ± 4.8 msec for inward and outward sIPSCs, respectively; n = 5 cells). On the basis of these observations, we assumed that outward sIPSCs were generated in dendritic compartments but that inward sIPSCs were generated near soma. Presynaptic GABAergic neurons of the network would generate inward and outward IPSCs if they formed synapses with all parts of the somatodendritic surface. Presynaptic neurons contacting restricted areas either near soma or in apical dendrites would generate a continuous barrage or clusters of inward or outward IPSCs consistent with their firing mode, continuous or in bursts. Assuming further that under the given recording conditions in the culture (see Discussion) soma and dendrites did not deviate considerably from isopotentiality, we had to postulate [Cl−]i to be lower in dendritic than in somatic compartments.
To examine compartmental differences in [Cl−]i we applied GABA (1 mm) focally to somatic and dendritic regions (Fig.2). To provide comparable conditions of origin for sIPSCs and GABA-evoked currents (IGABA), application was adjusted so that the amplitude of IGABA was in the range of amplitudes of sIPSCs. When tested in a voltage range around the reversal potential (EGABA ± 25 mV), slope conductances of dendritic and somatic IGABA were linear (Fig. 2). However, slope conductance was smaller for dendritic than for somatic applications, and often pressure or application time for the focal application had to be increased to obtain a measurable dendriticIGABA. The difference was probably caused by different density of receptors and/or surface size facing the application pipette if GABA was applied near soma or near dendrites. As expected from the observation of inward and outward sIPSCs, dendriticIGABA (application >100 μm away from soma) was outward at a VH at which somaticIGABA of the same cell was inward (Fig. 2). In a singe cell, EGABA differed by up to 25 mV (mean 12.9 ± 2.3 mV; n = 9) between soma and dendrites (Table 2).
Dependence of the somatodendritic Cl− gradient on a furosemide-sensitive transport
Calculation of inorganic [A−]ifrom EGABA values reported above revealed that dendritic [A−]i was lower than somatic [A−]i. If dendritic [Cl−]i was lowered by a furosemide-sensitive transport, it should be possible to reduce the somatodendritic [Cl−] gradient by furosemide application. Therefore, we tested the effects of furosemide on sIPSCs and IGABA. Furosemide altered the driving force for sIPSCs. At VH near the expectedEIPSC, amplitudes of inward sIPSCs increased and those of outward sIPSCs decreased or they reversed in sign (Fig. 3A). A new apparent steady state was achieved after maximally 1 min, and the effect of furosemide was fully reversible in a similar time. Effects of furosemide were observed at concentrations as low as 10 μm (Fig. 3B; n = 4 of 5 cells) and increased in a concentration-dependent manner (n = 9). The maximal concentration we used in all further experiments was 0.1 mm to avoid unspecific effects of furosemide (Cabantchik and Greger, 1992). To quantify the effect of furosemide onEGABA, current–voltage relationships forIGABA were determined in the presence and absence of furosemide (0.1 mm). In one series of experiments (n = 15), the position of the application pipette was guided by the current direction of sIPSCs. First, the range of VH was determined at which inward and outward sIPSCs were measurable. Thereafter, a VH at the positive side of this range was chosen to record predominantly outward sIPSCs that were likely generated in dendritic compartments (Fig.4A1). In this situation the position of the application pipette was chosen so thatIGABA was inward. In most instances the compartment reached from the soma up to 100 μm away from the somatic patch pipette for smoothly tapering dendrites (Fig. 2,inset). At a distance from soma of ∼200 μm, current direction of IGABA and sIPSCs concurred (Fig.4A2). Furosemide only slightly increased the amplitude of somatic IGABA (Fig.4A1), whereas dendritic IGABAreversed in sign (Fig. 4A2). As shown in Figure4B, a new steady-state for dendriticIGABA was achieved within 30–45 sec. The effect of furosemide was fully reversible. The data indicate a pronounced shift of EGABA under furosemide in dendrites but not at the soma.
In another set of experiments, furosemide (0.1 mm)-induced shifts in EGABA were quantified for dendritic (application ∼200 μm apart from soma) and somaticIGABA. As shown in Figure5A, furosemide shifted dendritic and somatic EGABA in positive direction but did not reduce slope conductance. This suggests that furosemide changed [A−]i but had no blocking action on GABAA receptors. Furosemide (0.1 mm) shifted somatic EGABA less than dendritic EGABA (4.2 ± 1.0 mV vs 11.8 ± 1.4 mV; n = 8) (Fig. 5B), with the result that furosemide reduced the somatodendritic inorganic [A−] gradient. These findings showed that at 15 mm [A−]pip and 2 mm [K+]o the somatic inorganic [A−]i was mainly governed by A− diffusion from the patch pipette into the cytoplasm of the cell body. Dendritic inorganic [A−] was significantly lowered with respect to somatic [A−]i by the operation of a furosemide-sensitive Cl− outward transport.
Dependence of the direction of the Cl−transport on [K+]o and [Cl−]i
The concentrations of furosemide used in our study inhibit the K+–Cl− cotransporter (KCC2) in heterologous expression systems. At concentrations of [Cl−]i (4–10 mm) and [K+]o (2–10 mm) that can be expected to occur in the mammalian brain, KCC2 operates near its thermodynamic equilibrium. The direction of Cl−transport depends on [Cl−]i and [K+]o (Payne, 1997). We tested whether these characteristics also apply to the regulation of Cl− homeostasis in neurons.
IGABA at 15 mm[A−]pip
Increasing [K+]o from 2 to 10 mm shifted dendritic EGABA to positive values (Table 2). An apparent, new steady state was attained only after the inward current elicited by [K+]o had peaked (Fig.6A1). When measured at 2 and 10 mm [K+]o in the same cells, the shift of dendritic EGABA mounted to 16.5 ± 3.3 mV (n = 3). In 10 mm[K+]o, furosemide (0.1 mm) shifted dendritic EGABA to even more positive values (3.3 ± 0.7 mV; n = 4), but the shift was consistently smaller than it had been at 2 mm[K+]o (11.8 ± 1.4 mV;n = 8) (Fig. 6A2–A4). This result corresponds to the expected diminution of the driving force for the K+–Cl− cotransporter at high [K+]o. Assuming that somatic inorganic [A−] was dominated by [A−]pip, elevation of [K+]o should not result in large changes in somatic EGABA. As expected, increasing [K+]o from 2 to 10 mm hardly changed somatic EGABA(1.0 ± 0.5 mV; n = 3) when tested in the same cells, and furosemide had no effect on somaticEGABA at 10 mm[K+]o (Table 2). Consequently, in 10 mm [K+]o and furosemide, there was little if any somatodendritic gradient for inorganic [A−].
IGABA at 4.5 mm[A−]pip
In the experiments presented above, the patch pipette was used to load the somatic compartment with moderate inorganic [A−]. To evaluate the role of [Cl−]i, we lowered [A−]pip (4.5 mm). With 4.5 mm [A−]pip, dendritic IGABA was more negative than with 15 mm [A−]pip (Table 2). According to the smaller driving force for the K+–Cl− cotransporter at 4.5 mm [A−]pip and 2 mm [K+]o, the furosemide (0.1 mm)-induced shift of dendriticEGABA was small (7.0 ± 0.9 mV;n = 6) (Fig. 6B). Increasing [K+]o from 2 to 10 mmstrongly shifted dendritic EGABA to positive values (27.8 ± 2.8 mV; n = 6). At 10 mm [K+]o, furosemide induced small shifts of dendriticEGABA; however, they were in the direction opposite to the shifts in 2 mm[K+]o (−5.0 ± 0.7 mV;n = 7) (Fig. 6B). These data indicate that at low [A−]pip the direction of the Cl− transport in the dendrites had been reversed by elevating [K+]o. At 2 mm [K+]o, [A−]pip and the furosemide-sensitive Cl− outward transport determined dendritic [Cl−]i, whereas at 10 mm [K+]o, dendritic [Cl−]i was governed by the Gibbs–Donnan equilibrium and the furosemide-sensitiveinward transport.
We next tested the effects of [K+]ochanges on somatic EGABA at low [A−]pip. At 2 mm[K+]o, somaticEGABA was more positive than dendriticEGABA (Table 2). However, elevation of [K+]o and application of furosemide (0.1 mm) had effects similar to those on dendriticEGABA (Table 2). At 2 mm[K+]o, furosemide shifted somatic EGABA to more positive values (4.2 ± 0.5 mV; n = 8). Elevating [K+]o from 2 to 10 mmshifted somatic EGABA in the same direction (7.0 ± 0.1 mV; n = 4) and reversed the shift of somatic EGABA under furosemide (−3.4 ± 0.6 mV; n = 6). In 10 mm[K+]o, therefore, no somatodendritic gradient for inorganic [A−]i existed in either the presence or absence of furosemide.
sIPSCs
Finally, we tested whether inward and outward sIPSCs were altered by [Cl−]i, [K+]o, and furosemide as expected from the data reported on IGABA. At 2 mm [K+]o and low [A−]pip, the mean amplitude of sIPSCs measured at different VH could not be fitted by a linear regression because sIPSCs appeared as inward and outward currents near EIPSC (n = 4) (Fig. 7A). Increasing [K+]o from 2 to 5 mm while recording from the same cell allowed the current–voltage relation to be fitted by a first order regression because the sIPSCs reversed in sign at a defined VH (Fig. 7B). At 5 mm [K+]o, the ratio of [Cl−]o/[Cl−]iapproximately equaled [K+]i/[K+]o; hence no driving force for an electroneutral K+–Cl− cotransport existed, leading to a collapse of the somatodendritic [A−] gradient. Furthermore, the time course of inward IPSCs measured near the reversal potential became slower in 5 mm[K+]o than apparent inward IPSCs had been in 2 mm [K+]o in the same cell (rise time, 1.48 ± 0.04 msec vs 1.00 ± 0.04 msec; time constant of decay, 16.5 ± 0.1 msec vs 7.1 ± 0.3 msec for 59 inward sIPSCs in 5 mm[K+]o and 37 inward sIPSCs in 2 mm [K+]o atVH −77 and −87 mV, respectively). As expected from the thermodynamic properties of the K+–Cl− cotransporter, increasing [K+]o to 8 mmat 4.5 mm [A−]pipreversed the transport direction of the Cl−transport. Under these conditions, furosemide decreased the amplitude of inward sIPSCs and increased the amplitude of outward sIPSCs (n = 3) (Fig. 8). The changes were the opposite of the changes induced by furosemide at 15 mm [A−]pip and low [K+]o (Fig. 3A).
DISCUSSION
Our data show that a furosemide-sensitive transport can accumulate or extrude Cl− from embryonic midbrain neurons in long-term culture. In terms of sensitivity to furosemide and to changes in [Cl−]i and [K+]o, the cotransporter exhibits functional characteristics described for the neuronal K+–Cl− cotransporter isoform (KCC2) expressed in human embryonic kidney cell lines (Payne, 1997). Because of the properties of the electroneutral K+–Cl− cotransporter, [K+]o determines the driving force for Cl− fluxes across GABAA receptor channels and hence regulates synaptic inhibition.
Reduction of a [Cl−]i gradient between dendrites and soma by furosemide or [K+]o
We observed a striking difference in driving forces for GABAA currents between cell soma and dendrites. Both, bicuculline-sensitive sIPSCs and focal GABA applications revealed the gradient. At a VH near the expected equilibrium potential for Cl−, GABAA currents were inward near soma and outward in dendritic parts. Furosemide reduced the somatodendritic differences in the driving forces, inducing a shift inEGABA that was more pronounced for dendritic currents than for somatic currents. A reduction of the somatodendritic gradient was also observed if [K+]owas increased or [A−]pip was reduced.
Dendritic [Cl−]i resulting under our experimental conditions (Fig.9A) can be explained from Gibbs–Donnan equilibrium and the thermodynamic profile of an electroneutral K+–Cl−cotransport (Fig. 9B). K+ and Cl− can be expected to be nearly in equilibrium across the neuronal membrane. [Cl−]iequal to [K+]o approximately satisfied the Donnan relationship as well as the principle of electroneutrality. [Cl−]i was actually increased above [Cl−]i predicted from the Donnan relationship or reduced below that concentration by a higher or lower [Cl−]pip, respectively. Near soma, [Cl−]pip determined [Cl−]i more closely than in the dendrites. Depending on [K+]o, dendritic [Cl−]i was lower (Fig.9Aa–Ac) or higher (Fig. 9Ad) than somatic [Cl−]i, indicating that Cl− movement across conductivity pathways exceeded Cl− diffusion from the patch pipette. The electroneutral K+–Cl−cotransporter contributed to the conductivity pathways according to its energy profile (Fig. 9B), as revealed by the shift in dendritic [Cl−]i resulting from furosemide application. When [K+]o was low and [Cl−]pip was high (Fig.9Aa), the driving force for the K+–Cl− cotransporter was sufficiently large to generate a pronounced somatodendritic gradient. The somatodendritic gradient was built up by the solution in the patch pipette, which served as a Cl− source, and the K+–Cl− cotransporter, which counteracted that Cl− load. The development of a Cl− gradient allowed us to study Cl− regulation, but the experiments did not determine under which conditions such a gradient may exist in intact neurons.
[Cl−]i calculated from somaticEGABA was always somewhat higher than [Cl−]pip. The small deviation was likely attributable to injected currents carried by anions because we set VH negative to the membrane potential. Supporting this suggestion, the relative increase of [Cl−]i above [Cl−]pip was larger with [Cl−]pip of 4.5 mm than with [Cl−]pip of 15 mm. The low mobility of the main anion glucuronate promoted an increase of [Cl−]i above [Cl−]pip. Other possible factors such as production of endogenous CO2 or the use of Br− were less likely contributors. An equal pH inside and outside the cells probably prevented buildup of a HCO3− gradient, and removal of the gradient for Br− had no measurable effect onEGABA (see Materials and Methods).
The observed fast and slow sIPSCs could represent an artifact of an imperfect space clamp. A similar finding was reported for GABAA responses in CA1 neurons of hippocampal slices (Pearce, 1993). In that study, arguments were put forward indicating that a space-clamp artifact did not account for the different time courses of synaptic currents generated at different locations of the neuron. In comparison, the analysis of IGABA in cultured neurons that have high input resistances (≥1 GΩ) and short dendrites (≤300 μm) recorded in the presence of TTX, QX314, and Cs+ should be much less hindered by geometrical factors (Müller and Lux, 1993; Draguhn et al., 1997). Furthermore, the slowing of the time course of inward sIPSCs when [K+]o was increased (Fig. 7) indicated that the time course of inward sIPSCs was shortened by superimposed small outward sIPSCs as long as the somatodendritic [Cl−]i gradient existed.
The neuronal-specific K+–Cl−cotransporter is inhibited by furosemide (Ki 25 μm) (Payne, 1997). Furosemide has been used to establish the involvement of a K+–Cl−cotransporter in synaptic inhibition (Misgeld et al., 1986; Thompson, 1994). Furosemide, however, has various disadvantages. In non-neuronal preparations, furosemide at concentrations >0.1 mminhibits not only cation–anion cotransporters but also other transport proteins and Cl− channels (Cabantchik and Greger, 1992). Here we could observe immediate effects of furosemide at concentrations below 0.1 mm. Furosemide has been reported to block GABAA channels that are composed of subunits including α4 and α6 (Wafford et al., 1996). These subunits are uncommon in midbrain areas (Wisden et al., 1992). In neither this nor a previous study (Jarolimek et al., 1996) on midbrain culture did we obtain evidence that furosemide reduced GABAA currents. Depending onVH, the amplitudes of IPSCs increased when neurons were exposed to furosemide, and slopes of current–voltage relationships for GABAA currents remained unaltered. As shown in the previous study (Jarolimek et al., 1996), shifts of reversal potentials of the same order of magnitude as those ofEGABA can be observed for glycine currents.
Furosemide blocks Na+–K+–Cl−cotransporters more effectively than it blocks the K+–Cl− cotransporter (Cabantchik and Greger, 1992). Thus, the furosemide effects described here do not allow discrimination between the two transporters. Our data, however, exclude a significant contribution of a Na+–K+–Cl−cotransporter in the net Cl− transport of cultured midbrain neurons. Because of the large inwardly directed driving force for Na+, the driving force of the net Cl− transport (Fig. 9Ac,d) would not reverse near [K+]o and [Cl−]i predicted from the driving force of a K+–Cl− cotransporter (Fig. 9Bc, d).
Regulation of the neuronal Cl− homeostasis by the furosemide-sensitive K+–Cl−cotransporter
The electroneutral K+–Cl−cotransporter operates near equilibrium under conditions of normal internal and external ion concentrations (Jensen et al., 1993; Payne, 1997). If [K+]o is kept at a high level (Fig. 9Ad), the K+–Cl− cotransporter accumulates Cl− in the cell. Under physiological conditions, Cl− accumulation would be diminished by the concomitant removal of K+ from the extracellular space (Payne, 1997). During epileptiform activity, however, [K+]o has been found to remain at high levels (10–12 mm) (Heinemann and Lux, 1977), with the result that the K+–Cl−transport actually accumulates Cl− and hence intensifies epileptiform activity. Therefore, furosemide may have some antiepileptic potency under such an experimental condition (Hochman et al., 1995). In contrast, in neuronal culture we observed that furosemide induced burst activity (Jarolimek et al., 1996). In these experiments, [K+]o was kept constant at 5 mm. In the presence of antagonists for ionotropic glutamate receptors, we observe frequent sIPSCs, suggesting that membrane potentials of the majority of cells are near to firing threshold, e.g. around −60 mV. The expected lower limit of [Cl−]i is around 5.6 mmin 5 mm [K+]o([Cl−]o = 169 mm; [K+]i assumed to be 150 mm). There is, however, an electromotor force (EM − ECl) driving Cl− into the cell. The hyperpolarizing gradient for synaptic inhibition will be maintained by the outwardly directed K+–Cl− cotransport. The upper limit of [Cl−]i is 20 mm if the K+–Cl−cotransporter is blocked by furosemide. Hence, in furosemide, the inhibitory potency of the GABAA postsynaptic potentials is diminished or abolished.
CONCLUSIONS
In cultured neurons, the regulation of [Cl−]i and the gradients for IPSCs is determined by the presence and activity of the K+–Cl− cotransporter. The driving force for the net Cl− transport is set by [K+]o and [Cl−]i. Values determined in this study indicate that [Cl−]i is kept well below 10 mm as long as [K+]o is 2 mm. Increases in [K+]o will increase [Cl−]i, but uptake of K+ into neurons on reversal of the transport will buffer [K+]o changes (Payne, 1997). However, if [K+]o remains high, the transport will accumulate Cl− in the cells.In vivo additional factors determine gradients for IPSCs through GABAA or glycine channels, complicating the analysis of their regulation. Despite this fact, a furosemide-sensitive K+–Cl− cotransporter is likely to operate in central neurons because the KCC2 mRNA is expressed in hippocampal neurons (Payne et al., 1996). The permeability for HCO3− shiftsEGABA by 10–15 mV (depending on pHi) in a positive direction (Alvarez-Leefmans, 1990; Kaila, 1994). A regulation of GABAergic inhibition through [HCO3−]i (Kaila, 1994) is less likely given the low permeability ratio of GABAAreceptors for HCO3−/Cl− (Bormann, 1988; Fatima-Shad and Barry, 1993). Furthermore, an inwardly rectifying chloride conductance (Smith et al., 1995), which does not appear to have a major influence in our cultured neurons (Jarolimek et al., 1996), may come into play. For an excitatory effect of GABA postnatally as opposed to an inhibitory effect in adult neurons (Cherubini et al., 1991), a transient dominance of a Na+–K+–Cl−cotransporter (LoTurco et al., 1995; Plotkin et al., 1997) probably coincides with a delayed expression of the K+–Cl− cotransporter (Zhang et al., 1991).
Footnotes
This work was supported by the Sonderforschungsbereich 317/B13 of the Deutsche Forschungsgemeinschaft (to U.M.). We thank Drs. F. Kuenzi and K. Wafford for comments on this manuscript and C. Heuser for excellent technical assistance.
Correspondence should be addressed to Dr. Ulrich Misgeld, I. Physiologisches Institut, Universität Heidelberg, Im Neuenheimer Feld 326, D-69120 Heidelberg, Germany.
Dr. Jarolimek’s present address: Merck Sharp & Dohme Research Laboratories, Neuroscience Research Centre, Terlings Park, Harlow, Essex CM 20 2QR, UK.